Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningitis, Meningococcal”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Large-scale testing (Phase 3)UnknownNCT03746665
What this trial is testing

Maternal Immunization With MenAfriVac™

Who this might be right for
MeningitisMeningococcal
London School of Hygiene and Tropical Medicine 200
Post-approval studies (Phase 4)Study completedNCT02864927
What this trial is testing

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,311
Large-scale testing (Phase 3)Study completedNCT01274897
What this trial is testing

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 450
Testing effectiveness (Phase 2)Study completedNCT00314041
What this trial is testing

Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 240
Testing effectiveness (Phase 2)Study completedNCT00269477
What this trial is testing

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 145
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Post-approval studies (Phase 4)Active Not RecruitingNCT06389513
What this trial is testing

Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 3,011
Large-scale testing (Phase 3)Study completedNCT01423084
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 344
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Post-approval studies (Phase 4)Study completedNCT00271479
What this trial is testing

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Infections, MeningococcalMeningitis, Meningococcic
Epicentre 720
Early research (Phase 1)Study completedNCT01661725
What this trial is testing

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001

Who this might be right for
Meningitis
Hualan Biological Engineering, Inc. 60
Not applicableStudy completedNCT03798574
What this trial is testing

The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults

Who this might be right for
Meningococcal InfectionsNeisseria Meningitis SepsisNeisseria Infection
University of Adelaide 98
Testing effectiveness (Phase 2)Study completedNCT01732627
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections+1 more
Sanofi Pasteur, a Sanofi Company 301
Large-scale testing (Phase 3)Study completedNCT01894919
What this trial is testing

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Who this might be right for
Meningoccocal DiseaseMeningococcal Meningitis
Novartis Vaccines 851
Early research (Phase 1)Study completedNCT00631995
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 360
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Testing effectiveness (Phase 2)Study completedNCT00310817
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 623
Testing effectiveness (Phase 2)Study completedNCT02946385
What this trial is testing

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 604
Load More Results